mozavaptan has been researched along with Inappropriate ADH Syndrome in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (52.63) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeuchi, K; Tamura, T | 1 |
| Iguchi, H; Kawahara, M; Kodama, T; Kuriyama, T; Mori, K; Sakurai, M; Shijubo, N; Shinkai, T; Sugiura, T; Yamaguchi, K | 1 |
| Villabona, C | 1 |
| Ferguson, JW; Hayes, PC; Newby, DE; Therapondos, G | 1 |
| Arata, T; Ejima, Y; Hatano, R; Kazama, I; Matsubara, M; Michimata, M; Miyama, N; Sasaki, S; Sato, A; Satomi, S; Suzuki, K; Suzuki, M | 1 |
| Ishikawa, SE; Sasaki, M | 1 |
| Arata, T; Ejima, Y; Hatano, R; Kazama, I; Matsubara, M; Michimata, M; Miyama, N; Sanada, S; Sasaki, S; Sato, A; Satomi, S; Suzuki, M | 1 |
| Gross, P; Herbrig, K; Palm, C; Pistrosch, F | 1 |
| Fujisawa, G; Ishikawa, S; Okada, K; Saito, T; Tsuboi, Y | 2 |
| Fujisawa, G; Fujita, N; Fushimi, K; Ishikawa, SE; Marumo, F; Saito, T; Sasaki, S | 1 |
| Saito, T | 1 |
| Abe, K; Ishikawa, S; Kamoi, K; Saito, T; Saruta, T; Shimizu, K; Yamada, K; Yoshida, S | 1 |
| Kamoi, K | 1 |
| Buchfelder, M; Gross, P; Hensen, J | 1 |
| Fujita, N; Ishikawa, S; Marumo, F; Saito, T; Sasaki, S | 1 |
| Ishikawa, S; Saito, T | 2 |
| Fleeman, LM; Irwin, PJ; Phillips, PA; West, J | 1 |
6 review(s) available for mozavaptan and Inappropriate ADH Syndrome
| Article | Year |
|---|---|
[Vasopressin receptor antagonists: the vaptans].
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins | 2010 |
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Diuretics; Heart Failure; Homeostasis; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Animal; Morpholines; Piperidines; Pyrroles; Quinolones; Rats; Spiro Compounds; Vasopressins | 2003 |
[Renal action of vasopressin].
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Benzazepines; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Drug Design; Humans; Hyponatremia; Inappropriate ADH Syndrome; Mutation; Piperidines; Quinolones; Receptors, Vasopressin | 2006 |
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Spiro Compounds; Tolvaptan; Vasopressins | 2006 |
SIADH and other hyponatremic disorders: diagnosis and therapeutic problems.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diagnosis, Differential; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kallikreins; Uric Acid | 1996 |
[Disorders of body water regulation and the therapy--vasopressin antagonists].
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Indoles; Liver Cirrhosis, Experimental; Pyrrolidines | 1997 |
2 trial(s) available for mozavaptan and Inappropriate ADH Syndrome
| Article | Year |
|---|---|
Clinical implication of the antidiuretic hormone (ADH) receptor antagonist mozavaptan hydrochloride in patients with ectopic ADH syndrome.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Antineoplastic Agents; Benzamides; Benzazepines; Biomarkers; Carcinoma, Small Cell; Female; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Palliative Care; Quality of Life; Sodium; Thymus Neoplasms; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2011 |
Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Topics: Aged; Arginine Vasopressin; Benzazepines; Diuresis; Diuretics; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Osmolar Concentration; Sodium; Treatment Outcome; Urine | 1997 |
11 other study(ies) available for mozavaptan and Inappropriate ADH Syndrome
| Article | Year |
|---|---|
Small cell gall bladder carcinoma complicated by syndrome of inappropriate secretion of antidiuretic hormone (SIADH) treated with mozavaptan.
Topics: Antidiuretic Hormone Receptor Antagonists; Antimetabolites, Antineoplastic; Benzazepines; Carcinoma, Small Cell; Deoxycytidine; Female; Gallbladder Neoplasms; Gemcitabine; Humans; Inappropriate ADH Syndrome; Middle Aged; Treatment Outcome | 2013 |
BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Aquaporins; Benzazepines; Deamino Arginine Vasopressin; Diuretics; Furosemide; Hyponatremia; Inappropriate ADH Syndrome; Kidney Medulla; Male; Potassium; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Urea; Water | 2005 |
Lithium effectively complements vasopressin V2 receptor antagonist in the treatment of hyponatraemia of SIADH rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzazepines; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Drug Synergism; Furosemide; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Lithium Chloride; Male; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin | 2007 |
Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats.
Topics: Animals; Benzazepines; Deamino Arginine Vasopressin; Hyponatremia; Inappropriate ADH Syndrome; Male; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Sodium; Vasopressins | 1993 |
Nonpeptide vasopressin antagonist and its application in the correction of experimental hyponatremia in rats.
Topics: Animals; Benzazepines; Cells, Cultured; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Muscle, Smooth, Vascular; Piperidines; Quinolones; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Vasopressins | 1993 |
Role of water channel AQP-CD in water retention in SIADH and cirrhotic rats.
Topics: Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Benzazepines; Blotting, Northern; Blotting, Western; Diuretics; Inappropriate ADH Syndrome; Ion Channels; Liver Cirrhosis, Experimental; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Water | 1995 |
Syndrome of inappropriate antidiuresis without involving inappropriate secretion of vasopressin in an elderly woman: effect of intravenous administration of the nonpeptide vasopressin V2 receptor antagonist OPC-31260.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Injections, Intravenous; Sodium; Vasopressins | 1997 |
[Aquaretic drugs--a new therapeutic principle in treatment of hyponatremia?].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney; Male; Vasopressins | 1997 |
Expression and subcellular localization of water channel aquaporin-2 in conscious rats.
Topics: Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Benzazepines; Inappropriate ADH Syndrome; Ion Channels; Liver Cirrhosis, Experimental; Male; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Rats, Wistar; RNA, Messenger; Subcellular Fractions; Tissue Distribution | 1997 |
Therapeutic efficacy of vasopressin receptor antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuresis; Edema; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Rats | 1998 |
Effects of an oral vasopressin receptor antagonist (OPC-31260) in a dog with syndrome of inappropriate secretion of antidiuretic hormone.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dog Diseases; Dogs; Inappropriate ADH Syndrome; Male; Sodium | 2000 |